Nolan Garry Ph.D.
- SEC CIK
- 0001857405
No open-market purchases or sales filed in the past year.
Current role at each company
- AKYA Akoya Biosciences, Inc.Directoras of Jun 5, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Nolan Garry Ph.D. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 27, 2023 (view filing) | Dec 13, 2022 | 104 days | Nolan Garry Ph.D.Director | SSale | −100 | $13.25 | −$1.32K | 0.0%555.1K after | Amended |
| Dec 6, 2022 (view filing) | Dec 2 | 4 days | Nolan Garry Ph.D.Director | SSale | −1.10K | $13.25 | −$14.6K | −0.2%592.0K after | |
| Dec 2, 2022 (view filing) | Dec 1 | 1 day | Nolan Garry Ph.D.Director | SSale | −5.00K | $13.36 | −$66.8K | −0.8%593.1K after | |
| Nov 17, 2022 (view filing) | Nov 16 | 1 day | Nolan Garry Ph.D.Director | SSale | −300 | $13.25 | −$3.98K | −0.1%598.1K after | |
| Nov 14, 2022 (view filing) | Nov 10-14 | 4 days | Nolan Garry Ph.D.Director | SSale | −24.4K | $13.29 | −$324.5K | −3.9%598.4K after | 3 lots |
| Sep 16, 2022 (view filing) | Sep 14 | 2 days | Nolan Garry Ph.D.Director | SSale | −8.30K | $13.26 | −$110.1K | −1.3%622.8K after | |
| Sep 13, 2022 (view filing) | Sep 9-12 | 4 days | Nolan Garry Ph.D.Director | SSale | −24.0K | $13.31 | −$319.3K | −3.7%631.1K after | 2 lots |
| Dec 13, 2021 (view filing) | Dec 9 | 4 days | Nolan Garry Ph.D.Director | SSale | −25.0K | $12.67 | −$316.8K | −3.7%655.1K after |